The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bobrov A.E.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii, Moskva

Starostina E.G.

FGUZ "Moskovskiĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut (MONIKI) im. M.F. Vladimirskogo"

Alexandrova M.M.

Pirogov Russian National Research University, Moscow, Russia, Vladimirsky Moscow Regional Clinical and Research Institute, Moscow, Russia

Mental disorders in patients with acromegaly

Authors:

Bobrov A.E., Starostina E.G., Alexandrova M.M.

More about the authors

Read: 1850 times


To cite this article:

Bobrov AE, Starostina EG, Alexandrova MM. Mental disorders in patients with acromegaly. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9):18‑23. (In Russ.)
https://doi.org/10.17116/jnevro20161169118-23

Recommended articles:
Aripiprazole in the treatment of psychiatric diso­rders in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):38-47

References:

  1. Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S. Clinical, quality of life, and economic value of acromegaly disease control. Pituitary. 2011;14(3):284-294.  doi: 10.1007/s11102-011-0310-7
  2. Dreval' AV. Jendokrinologija. Rukovodstvo dlja vrachej. M.: GJeOTAR-Media; 2016. (In Russ.).
  3. Kazunori A, Kaoru K, Atushi T, Kuniki E, Koji I, Tohru U, Fumiyoshi K. Mortality in 154 Surgically Treated Patients with Acromegaly-A 10-year Follow-Up Survey. Endocrine Journal. 2003;(50):163-172.  doi: 10.1507/endocrj.50.163
  4. Kauppinen-Mäkelin R, Sane T, Reunanen A, Välimäki MJ, Niskanen L, Markkanen H, Löyttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J, Voutilainen E. A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab. 2005;90(7),4081-4086. doi:10.1210/jc.2004-1381
  5. Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK. High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clinical Endocrinology. 2008;69(3):432-435.  doi: 10.1111/j.1365-2265.2008.03221
  6. Orlovskaja DD. Obshhaja harakteristika psihicheskih rasstrojstv pri jendokrinopatijah. V kn. pod red. Snezhnevskogo AV. Rukovodstvo po psihiatrii. T. 2. M.: Medicina; 1983. (In Russ.).
  7. Brambilla F. Psychopathological Aspects of Neuroendocrine Diseases: Possible Parallels with the Psychoendocrine Aspects of Normal Aging. Psychoneuroendocrinology. 1992;17(4):283-291.  doi: 10.1016/0306-4530(92)90035-6
  8. Krechmer Je. Stroenie tela i harakter. M.: Gosudarstvennoe izdatel'stvo medicinskoj literatury; 1930. (In Russ.).
  9. Bleuler M. Endocrinologische Psychiatrie. Cit. po Belkinu AI. Zhurnal nevropatologii i psihiatrii im. S.S. Korsakova. 1957:57(2):271-282. (In Russ.).
  10. Abed RT, Clark J, Elbadawy MH, Cliffe MJ. Psychiatric morbidity in acromegaly. Acta Psychiatrica Scandinavica. 1987;75(6):635-639.  doi:10.1111/j.1600-0447.1987.tb02848.x
  11. Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J. Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clinical Endocrinology. 2009;71:691-701.  doi: 10.1111/j.1365-2265.2009.03555.x
  12. Iglesias P, Bernal C, Díez J. Curious cases: Acromegaly and schizophrenia: an incidental association? Schizophr Bull. 2014;40(4):740-743.  doi: 10.1093/schbul/sbu028
  13. Dobrohotova TA, Faller TO. Psihopatologicheskie sindromy pri opuholjah hiazmal'no-selljarnoj oblasti. V kn.: Opuholi hiazmal'no-selljarnoj oblasti. M.: Medicina; 1976. (In Russ.).
  14. Pantanetti P, Sonino N, Arnaldi G, Boscaro M. Self image and quality of life in acromegaly. Pituitary. 2002;5(1):17-19.  doi: 10.1023/a:1022145116901
  15. Brummelman P, Koerts J, Dullaart RP, van den Berg G, Tucha O, Wolffenbuttel BH, van Beek AP. Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. European Journal of Clinical Investigation. 2012;42(12):1317-1224. doi: 10.1111/j.1365-2362.2012.02721.x
  16. Dedov II, Molitvoslovova NN, Rozhinskaja LYa, Mel'nichenko GA. Federal'nye klinicheskie rekomendacii po klinike, diagnostike, differencial'noj diagnostike i metodam lechenija akromegalii. Problemy jendokrinologii. 2013;6:4-18. (In Russ.). doi: 10.14341/probl20135964-18
  17. Dreval' AV, Kamynina TS, Nechaeva OA, Pokramovich YuG. Moskovskij oblastnoj registr bol'nyh akromegaliej. Problemy jendokrinologii. 2008;54(4):27-31. (In Russ.).
  18. VOZ. Mezhdunarodnaja klassifikacija boleznej (10-j peresmotr). Klassifikacija psihicheskih i povedencheskih rasstrojstv. Klinicheskie opisanija i ukazanija po diagnostike. Per. na rus. Nullera YuL, Cirkina SYu. SPb.: Overlajd; 1994/ (In Russ.).
  19. Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for granding the cognitive state of patients for the clinician. Journal of psychiatric research. 1975;12:189-198.
  20. Mosolov SN, Ushkalova AV, Kostyukova EG, Shafarenko AA, Alfimov PV., Kostjukova AB, Kursakov AA, Obrazcova LV. Validizacija rossijskoj versii oprosnika HCL-32 dlja vyjavlenija pacientov s bipoljarnym affektivnym rasstrojstvom II tipa sredi bol'nyh, nabljudajushhihsja s diagnozom rekurrentnogo depressivnogo jepizoda Social'naja i klinicheskaja psihiatrija. 2015;25(1):21-30.  doi: 10.1016/j.jad.2013.10.029
  21. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer T, Skeppar P, Vieta E, Scott J. The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders. 2005;88(2):217-233. (In Russ.). doi: 10.1016/j.jad.2005.05.011
  22. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am. 1999;22(3):517-534.  doi: 10.1016/s0193-953x(05)70093-9
  23. Rukovodstvo po psihiatrii. Pod red. Snezhnevskogo AV. M.: Medicina; 1983. (In Russ.).
  24. Crum R, Anthony J, Bassett S, Folstein M. Population-Based Norms for the Mini-Mental State Examination by Age and Educational Level. JAMA, 1993;269(18):2386-2391. doi: 10.1001/jama.1993.03500180078038
  25. Bleuler M. Personality changes in pituitary disorders. British Medical Journal. 1951;1(4706):580-581.  doi: 10.1136/bmj.1.4706.580
  26. Celibeev BA. Psihicheskie narushenija pri jendokrinnyh zabolevanijah. M.: Medicina; 1966. (In Russ.).
  27. Krasnushkin EK. O nekotoryh otnoshenijah mezhdu dushevnymi i somaticheskimi zabolevanijami. Nevropatologija i psihiatrija. 1942;1-2:20-32. (In Russ.).
  28. Bobrov AE, Mel'nichenko GA, Pjatnickij NJu, Bondarenko MG. Osobennosti psihicheskih sostojanij u bol'nyh s pervichnoj giperprolaktinemiej. Problemy jendokrinologii. 1995;41(2):22-25. (In Russ.).
  29. Dobrzhanskaja AK. Psihicheskie i nejrofiziologicheskie narushenija pri jendokrinnyh zabolevanijah. M.: Medicina; 1973. (In Russ.).
  30. Jablensky A. Prevalence and incidence of schizophrenia spectrum disorders: implications for prevention. Aust N Z J Psychiatry. 2000;34(suppl):26-34.  doi: 10.1046/j.1440-1614.2000.00770.x
  31. Robins L, Wing J, Wittchen H, Helzer J, Babor T, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, Sartorius N, Towle L. The Composite International Diagnostic Interview: An Epidemiologic Instrument Suitable for Use in Conjunction With Different Diagnostic Systems and in Different Cultures. Arch Gen Psychiatry. 1988;45(12):1069-1077. doi: 10.1001/archpsyc.1988.01800360017003
  32. Goldney RD, Fisher LJ, Hawthorne G. Depression and the CIDI. British Journal of Psychiatry. 2004;185:518-519.  doi: 10.1192/bjp.185.6.518-a
  33. Benazzi F, Akiskal H. The modified SCID Hypomania Module (SCID-Hba): A detailed systematic phenomenologic probing. Journal of Affective Disorders. 2009;117(3):131-136.  doi: 10.1016/j.jad.2009.06.001
  34. Mcdonald KC, Bulloch AG, Duffy A, Bresee L, Williams JV, Lavorato DH, Patten SB. Prevalence of Bipolar I and II Disorder in Canada. Can J Psychiatry. 2015;60(3):151-156.
  35. Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, Gillin JC, Smith TL. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. Journal of Affective Disorders. 2005;85(1-2):45-52.  doi: 10.1016/j.jad.2003.10.012
  36. Liu X, Zhang T, He S, Hong B, Chen Z, Peng D, Wu Y, Wen H, Lin Z, Fang Y, Jiang K. Elevated serum levels of FGF2, NGF and IGF1 in patients with manicepisode of bipolar disorder. Psychiatry Re. 2014;218(1-2):5460. doi: 10.1016/j.psychres.2014.03.042
  37. Kim YK, Na KS, Hwang JA, Yoon HK, Lee HJ, Hahn SW, Lee BH, Jung HY. High insulinlike growth factor1 in patients with bipolar I disorder: a trait marker? J Affect Disord. 2013;151(2):738-743.  doi: 10.1016/j.jad.2013.07.041
  38. Prokudin VN. Pjatiletnij opyt organizacii psihoterapevticheskoj, psihiatricheskoj i narkologicheskoj pomoshhi v somaticheskoj bol'nice. Social'naja i klinicheskaja psihiatrija. 2005;2:73-78. (In Russ.).
  39. Prokudin V, Boyko Y, Kyrov N. The peculiarities of organization consultative liaision psychiatry/psychotherapy in multiprofile general hospital (12-years experience). European Psychiatry. 2010;25(1):510.  doi: 10.1016/S0924-9338(10)70505-8
  40. Dreval' AV, Trigolosova IV, Vinogradova AV, Ilovajskaja IA. Rasprostranennost' saharnogo diabeta sredi bol'nyh akromegaliej. Problemy jendokrinologii. 2012;58(3):9-11.  doi: 10.14341/probl20125839-11 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.